drugset / Trial / NCT00033111

A Study of Cabergoline for the Treatment of Cocaine Dependence - 1

NCT00033111

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess cabergoline for the Treatment of Cocaine Dependence

Timeline

Start
2001-06
Primary completion
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cabergoline Small molecule 0.5 mg

Indications